{
    "2021-01-12": [
        [
            {
                "time": "2020-11",
                "original_text": "【山证医药】2020年1-11月血制品批签发数据跟踪报告：11月同比下降 1-11月仍维持增长",
                "features": {
                    "keywords": [
                        "血制品",
                        "批签发",
                        "同比下降",
                        "维持增长"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020",
                "original_text": "天坛生物(600161)：业绩基本符合预期 受益于云南省2020-2023单采血浆站设置规划 浆量成长性进一步确定",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "业绩",
                        "云南省",
                        "单采血浆站",
                        "浆量成长性"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-12",
                "original_text": "2020年1-12月血制品批签发：Q4国产人白持续下滑",
                "features": {
                    "keywords": [
                        "血制品",
                        "批签发",
                        "Q4",
                        "国产人白",
                        "持续下滑"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "首席周观点：本期重点 二线电池企业发展机会渐增 投资价值向上",
                "features": {
                    "keywords": [
                        "二线电池企业",
                        "发展机会",
                        "投资价值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "首席周度观点：新冠疫苗向公众免费 国内预防免疫积极推进",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "公众免费",
                        "预防免疫",
                        "积极推进"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中信建投：疫情催化、年报加持，医药行业关注度有望提升",
                "features": {
                    "keywords": [
                        "疫情催化",
                        "年报加持",
                        "医药行业",
                        "关注度提升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}